Description
Book SynopsisShows how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended.
Trade Review'Bad Medicine offers a wealth of information which is urgently needed by health policy planners, health professionals, consumers, and the pharmaceutical industry. To my knowledge, this objective and well-documented data, which is thoroughly assessed and interpreted, is available nowhere else. The book shows in detail which companies are promoting their products with honesty and responsibility and which companies are still trying to treat doctors and patients. Furthermore, it holds the reader's attention from first to last.' Dr. Klaus von Grebmer, Giba-Geigy, Switzerland
Table of ContentsPreface A note about the authors 1. The patients: health for all by - when? 2. Drug labelling: how safe? how deadly? 3. The companies: heroes or villains? 4. The great generics controversy 5. The dipyrone affair 6. The case of the deadly pregnancy test 7. Bangladesh and the noble experiment 8. The drug swindlers 9. So shines a good deed 10. Ammunition for the consumers 11. Consumer power: the Hansson/Ciba-Geigy connection 12. The essential role of government 13. hard choices Appendix References Index.
